– Rapidly transforming into a leading global biopharma company…
COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones. Ascendis President and CEO Jan Mikkelsen will present t… [12153 chars]
Source: GlobeNewswire | Published: 2026-01-09T23:01:32Z
Credit: GlobeNewswire
